Tech Company Financing Transactions

TheraVida Funding Round

On 3/31/2015, TheraVida raised $300 thousand in funding from Sanderling Ventures and private investors.

Transaction Overview

Company Name
Announced On
3/31/2015
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Investors

Sanderling Ventures (Roger Flugel)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4819 Emperor Blvd. 400
Durham, NC 27517
USA
Email Address
Overview
Using a unique and patent-protected combination drug technology, TheraVida is able to develop urology pharmaceutical products that have significantly better side effect and safety profiles, when compared with predecessor therapies.
Profile
TheraVida LinkedIn Company Profile
Social Media
TheraVida Company Twitter Account
Company News
TheraVida News
Facebook
TheraVida on Facebook
YouTube
TheraVida on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Benjamin McGraw
  Benjamin McGraw LinkedIn Profile  Benjamin McGraw Twitter Account  Benjamin McGraw News  Benjamin McGraw on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2015: Intellihot venture capital transaction
Next: 3/31/2015: Iconic Therapeutics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary